SpringWorks Therapeutics Inc (SWTX) Company Profile & Statistics

SpringWorks Therapeutics Inc
SWTX
(Nasdaq - US)
Open
35.91
-0.54 (-1.48%)
in:usd•As of: Nov 18, 2024 12:42 UTC -5
Open
36.99
High
36.99
Low
35.51

About SpringWorks Therapeutics Inc

CEO

Saqib Islam

Headquarters

100 washington boulevard

stamford, ct 06902, united states

Auditor

Ernst & Young LLP

Employees

305

Share Holders

Website

www.springworkstx.com

Industry

biotechnology

Sector

health technology

Company Overview

SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.

SpringWorks Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	2.67B
Enterprise Value	2.59B
Enterprise Value/EBITDA (ttm)	-8.69
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	5.08
Price to Sales (ttm)	20.01
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	70.85%
Operating Margin (ttm)	-203.09%
Profit Margin (ttm)	-147.85%
Return on Equity (ttm)	-48.21%
Return on Invested Capital (ttm)	-47.68%
Return on Assets (ttm)	-42.19%

Income Statement

Revenue (ttm)	130.04M
Revenue Per Share (ttm)	1.75
Gross Profit (ttm)	123.04M
EBITDA (ttm)³	-297.71M
Net Income Avi to Common (ttm)	-275.16M
Diluted EPS (ttm)	-3.88

Share Statistics

Beta (5Y Monthly)	0.79
52-Week Change	61.61%
S&P500 52-Week Change	29.70%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	74.39M
Dividend Yield	0.00%
Float ⁴	68.72M
% Held by Insiders	7.61%
% Held by Institutions	N/A

Balance Sheet

Total Cash (mrq)	376.62M
Total Cash Per Share (mrq)	5.06
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.16%
Quick Ratio (mrq)	6.02%
Book Value Per Share (mrq)	7.16

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.97
Free Cash Flow (ytd)	-149.50M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

SpringWorks Therapeutics Inc

Trade With A Regulated Broker